Literature DB >> 23419918

Long-term aerobic exercise maintains peak VO(2), improves quality of life, and reduces hospitalisations and mortality in patients with heart failure.

Bo Fernhall1.   

Abstract

QUESTION: Does aerobic exercise improve peak VO(2), quality of life, all-cause mortality, and cardiovascular morbidity in patients with chronic heart failure with mild to moderate symptoms?
DESIGN: Randomised, controlled trial with blinded outcome assessment.
SETTING: Hospital and community settings in Italy. PARTICIPANTS: Patients with chronic heart failure who were clinically stable, had a left ventricular ejection fraction < 40%, and the ability to exercise. Haemodynamically significant valvular heart disease, uncontrolled diabetes or hypertension, and renal insufficiency were exclusion criteria. One hundred and thirty-five patients enrolled in the study and 123 completed the protocol. Randomisation of 123 participants (78% male) allotted 63 to the exercise group and 60 to a usual care group.
INTERVENTIONS: Both groups received counselling on smoking cessation, stress reduction and diet. In addition, the intervention group participated in an exercise training program for 10 years. The program consisted of 3×1-hour sessions per week of aerobic exercise at 60% peak VO(2) at a hospital for 2 months under the supervision of a cardiologist and an exercise therapist, and 2 supervised 1-hour sessions at 70% peak VO(2) the rest of the year in a community setting. Patients were also encouraged to exercise at home at least once a week. Each exercise session included 40 minutes of aerobic activity (cycling and treadmill). The control group received usual care and were advised to continue their usual physical activities for no longer than 30 minutes each session. OUTCOME MEASURES: The primary outcomes were functional capacity, measured by peak VO(2) as a percentage of predicted maximum VO(2), and quality of life over 10 years. Quality of life was measured using the 21-item Minnesota living with heart failure questionnaire (maximum score 105 points). Secondary outcomes were hospitalisations and cardiac mortality.
RESULTS: At 10-years, the exercise group had maintained a higher peak VO(2) as a percentage of predicted maximum VO(2) compared with the control group (mean difference 13%, 95% CI 11 to 15). Quality of life was significantly better in the exercise group than the control group at 12 months (by 15 points (95% CI 10 to 20) and this was sustained throughout the 10 year study period. The groups differed significantly on the relative risk (hazard ratios) of hospital readmission (0.6, 95% CI 0.3 to 0.8) and cardiac death (0.6, 95% CI 0.3 to 0.8) in favour of the exercise training group.
CONCLUSION: Moderate intensity supervised aerobic exercise for patients with chronic heart failure performed at least twice-weekly for 10 years maintains functional capacity at more than 60% predicted maximum VO(2). It also offers a sustained improvement in quality of life and a reduction in hospitalisations and cardiac mortality.
Copyright © 2013 Australian Physiotherapy Association. Published by .. All rights reserved.

Entities:  

Year:  2013        PMID: 23419918     DOI: 10.1016/S1836-9553(13)70149-8

Source DB:  PubMed          Journal:  J Physiother        ISSN: 1836-9561            Impact factor:   7.000


  8 in total

1.  Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K/Akt signaling to improve the effects of exercise in elderly rat hearts.

Authors:  Chih-Hsueh Lin; Cheng-Chieh Lin; Wei-Jen Ting; Pei-Ying Pai; Chia-Hua Kuo; Tsung-Jung Ho; Wei-Wen Kuo; Chung-Ho Chang; Chih-Yang Huang; Wan-Teng Lin
Journal:  Age (Dordr)       Date:  2014-08-27

Review 2.  Adherence to recommended exercise guidelines in patients with heart failure.

Authors:  Pallav Deka; Bunny Pozehl; Mark A Williams; Bernice Yates
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

3.  Exercise-based cardiac rehabilitation for adults with heart failure.

Authors:  Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2019-01-29

Review 4.  New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure.

Authors:  Jiayu Yin; Xiang Lu; Zhiyuan Qian; Weiting Xu; Xiang Zhou
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

5.  Assessment of Measurement Reliability for the IPN Test in Cardiac Patients.

Authors:  Łukasz Oleksy; Agnieszka Skiba; Iwona Sulowska; Marcin Trębowicz; Bartosz Rukasz; Artur Stolarczyk; Joanna Zyznawska; Anna Mika
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

6.  The effect of baduanjin on promoting the physical fitness and health of adults.

Authors:  Ran Li; Li Jin; Ping Hong; Zi-Hong He; Chuan-Ye Huang; Jie-Xiu Zhao; Mei Wang; Ye Tian
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-23       Impact factor: 2.629

7.  Anti-Apoptotic and Pro-Survival Effect of Alpinate Oxyphyllae Fructus (AOF) in a d-Galactose-Induced Aging Heart.

Authors:  Yung-Ming Chang; Hen-Hong Chang; Wei-Wen Kuo; Hung-Jen Lin; Yu-Lan Yeh; Vijaya Padma Viswanadha; Chin-Chuan Tsai; Ray-Jade Chen; Hsin-Nung Chang; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2016-03-29       Impact factor: 5.923

8.  The evolution of universal adaptations of life is driven by universal properties of matter: energy, entropy, and interaction.

Authors:  Irun R Cohen; Assaf Marron
Journal:  F1000Res       Date:  2020-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.